Table 1

Main meta-analyses

OutcomeExposure/insultKOR95% CIP valueHeterogeneity
Lower limitUpper limitI2 (%)P value
All BPD (BPD28)Hypertensive disorders of pregnancy (HDP)Any HDP130.9270.6361.3520.69562.80.001
Pre-eclampsia141.0580.7561.4820.74259.40.002
Pre-eclampsia/HELLP60.7710.4651.2790.31464.70.015
HDP overall330.9490.7571.1880.64561.9<0.001
SGA/IUGRBW <P10270.8230.6181.0960.18264.7<0.001
BW <P3 or −2SD41.2340.5992.5410.56982.90.001
IUGR21.2670.5323.0180.5350.00.546
IUGR/SGA overall330.8980.6961.1580.40866.2<0.001
Moderate/severe
BPD (BPD36)
HDPAny HDP271.0660.9141.2430.81068.9<0.001
Pre-eclampsia311.0930.8691.3750.44883.8<0.001
Pre-eclampsia/HELLP31.0220.7621.3720.88275.80.017
HDP overall611.0660.9481.1980.28879.8<0.001
SGA/IUGRBW <P10571.5501.3081.837<0.00185.7<0.001
BW <P521.6510.6594.1380.2840.00.674
BW <P3 or −2SD231.4601.1301.8840.00487.8<0.001
IUGR92.2511.5373.297<0.00180.0<0.001
SGA/IUGR overall911.5641.3691.785<0.00185.5<0.001
Severe BPDHDPHDP overall*80.9400.5821.5170.79941.80.100
SGA/IUGRBW <P10111.4911.0012.2200.04934.50.123
BW <P342.2771.2964.0310.0050.00.788
IUGR22.2851.2204.2900.01071.60.061
SGA/IUGR overall171.8211.3632.288<0.00124.50.171
BPD or deathHDPHDP overall*80.7710.6350.9370.00938.90.120
SGA/IUGRBW <P10121.7921.3872.315<0.00190.5<0.001
BW <P512.9700.8999.8140.0740.01.000
BW <P3 or −2SD22.5381.3234.8690.00554.10.140
IUGR31.9341.1263.3230.01787.7<0.001
SGA/IUGR overall181.9141.5452.373<0.00188.7<0.001
BPD-associated pulmonary hypertensionHDPAny HDP111.4081.0341.9170.03038.30.094
Pre-eclampsia91.4180.9442.1280.0920.00.554
HDP overall201.4121.1041.8050.00618.30.227
SGA/IUGRBW <P10172.2751.7712.922<0.00140.80.041
BW <P3 or −2SD34.4181.68911.5560.0020.00.390
SGA/IUGR overall202.3731.8623.023<0.00138.70.040
  • Mixed effects analysis. A random effects model is used to combine studies within each subgroup. A fixed effect model is used to combine subgroups and yield the overall effect.

  • *Studies were not divided into subgroups because K<10 . OR >1 indicates association with increased risk of the outcome and OR <1 indicates association with decreased risk of the outcome.

  • BPD28, BPD defined as oxygen requirement on postnatal day 28; BPD36, BPD defined as oxygen requirement at the postmenstrual age of 36 weeks; BPD, bronchopulmonary dysplasia; BW, birth weight; IUGR, intrauterine growth restriction (defined on the basis of fetal growth assessment); K, number of studies; P3, third percentile; P5, 5th percentile; P10, 10th percentile; SGA, small for gestational age.